Summary by Moomoo AI
On July 5, 2024, Hutchison Medicine (2171.HK) submitted the monthly report on securities changes as of June 30, 2024 to Hong Kong Exchanges and Clearing Limited. The report shows that the statutory/registered share capital of the company remains unchanged at US$50,000, while the issued shares (excluding treasury shares) increased from 575,653,415 shares at the end of last month to 575,675,415 shares, an increase of 22,000 shares. In addition, according to the stock-based incentive plan for 2019, the number of newly issued shares that may be issued is 3,766,992 shares. The company also repurchased 4,135,500 common shares during May and June, but they have not been cancelled as of the reporting date. The report confirms that all sales or transfers of securities issued or treasury shares have been formally authorized by the board of directors and are in compliance with all applicable listing rules, laws and other regulatory provisions.
